1-3 of 3
Maria T. Kuipers
Close
Sort by
Journal Articles

Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data

Clinical Trials & Observations
Flores Weverling, Mieke Roeven, Clara Nijssen, Annoek E. C. Broers, Elisabeth Dovern, Anna van Rhenen, Geerte van Sluis, Carin L. E. Hazenberg, Peter van Balen, Maria T. Kuipers, Karen M. K. de Vooght, Linde Morsink, Jürgen Kuball, Erfan Nur, Moniek A. de Witte
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1683–1686.
https://doi.org/10.1182/bloodadvances.2023011190
Published: 2024
Includes: Supplemental data
Journal Articles

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

Kristine A. Frerichs, Christie P. M. Verkleij, Maria Victoria Mateos, Thomas G. Martin, Cesar Rodriguez, Ajay Nooka, Arnob Banerjee, Katherine Chastain, Alfredo Perales-Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Bronno van der Holt, Sandy Kruyswijk, Maria T. Kuipers, Kaz Groen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, Margaret Doyle, Hans L. Zaaijer, Sonja Zweegman, Raluca I. Verona, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2023) 8 (1): 194–206.
https://doi.org/10.1182/bloodadvances.2023011658
Published: 2023
Includes: Supplemental data
Journal Articles

Inflammatory reactions mimic residual or recurrent lymphoma on [ 18 F]FDG-PET/CT after CD19-directed CAR T-cell therapy

Janneke W. de Boer, Elise R. A. Pennings, Ankie Kleinjan, Jaap A. van Doesum, Anne M. Spanjaart, Pim G. N. J. Mutsaers, Margot Jak, Marjolein W. M. van der Poel, Maria T. Kuipers, Judit A. Adam, Arjan Diepstra, Lianne Koens, Suzanne van Dorp, Joost S. P. Vermaat, Anne G. H. Niezink, Marie José Kersten, Tom van Meerten
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6710–6716.
https://doi.org/10.1182/bloodadvances.2023010665
Published: 2023